{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:47:58Z","timestamp":1777502878482,"version":"3.51.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T00:00:00Z","timestamp":1448236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T00:00:00Z","timestamp":1448236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Epstein Barr virus (EBV) sequence variation is thought to contribute to Burkitt lymphoma (BL), but lack of data from primary BL tumors hampers efforts to test this hypothesis. We directly sequenced EBV from 12\u2009BL biopsies from Ghana, Brazil and Argentina, aligned the obtained reads to the wild-type (WT) EBV reference sequence and compared them with 100 published EBV genomes from normal and diseased people from around the world. The 12\u2009BL EBVs were Type 1. Eleven clustered close to each other and to EBV from Raji BL cell line, but away from 12\u2009EBVs reported from other BL-derived cell lines and away from EBV from NPC and healthy people from Asia. We discovered 23 shared novel nucleotide-base changes in the latent membrane protein (LMP)-1 promoter and gene (associated with 9 novel amino acid changes in the LMP-1 protein) of the 11 BL EBVs. Alignment of this region for the 112 EBV genomes revealed four distinct patterns, tentatively termed patterns A to D. The distribution of BL EBVs was 48%, 8%, 24% and 20% for patterns A to D, respectively; the NPC EBV\u2019s were Pattern B and EBV-WT was pattern D. Further work is needed to investigate the association between EBV LMP-1 patterns with BL.<\/jats:p>","DOI":"10.1038\/srep16706","type":"journal-article","created":{"date-parts":[[2015,11,23]],"date-time":"2015-11-23T11:02:27Z","timestamp":1448276547000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Epstein-Barr virus from Burkitt Lymphoma biopsies from Africa and South America share novel LMP-1 promoter and gene variations"],"prefix":"10.1038","volume":"5","author":[{"given":"Haiyan","family":"Lei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shien","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Biggar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis","family":"Nkrumah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Neequaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidnei","family":"Epelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam M.","family":"Mbulaiteye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kishor","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyh-Ching","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,23]]},"reference":[{"key":"BFsrep16706_CR1","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","volume":"1","author":"MA Epstein","year":"1964","unstructured":"Epstein, M. A., Achong, B. G. & Barr, Y. M. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 1, 702\u2013703 (1964).","journal-title":"Lancet"},{"key":"BFsrep16706_CR2","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/j.1365-2796.2008.02031.x","volume":"264","author":"H Hjalgrim","year":"2008","unstructured":"Hjalgrim, H. & Engels, E. A. Infectious aetiology of Hodgkin and non-Hodgkin lymphomas: A review of the epidemiological evidence. J Intern Med 264, 537\u2013548 (2008).","journal-title":"J Intern Med"},{"key":"BFsrep16706_CR3","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1002\/(SICI)1097-0142(19960515)77:10<2137::AID-CNCR27>3.0.CO;2-V","volume":"77","author":"Y Harabuchi","year":"1996","unstructured":"Harabuchi, Y. et al. Nasal t-cell lymphoma causally associated with Epstein-Barr virus: Clinicopathologic, phenotypic and genotypic studies. Cancer 77, 2137\u20132149 (1996).","journal-title":"Cancer"},{"key":"BFsrep16706_CR4","first-page":"349","volume":"19","author":"G de The","year":"1973","unstructured":"de The, G., Ablashi, D. V., Liabeuf, A. & Mourali, N. Nasopharyngeal carcinoma (npc). Vi. Presence of an EBV nuclear antigen in fresh tumour biopsies. Preliminary results. Biomedicine 19, 349\u2013352 (1973).","journal-title":"Biomedicine"},{"key":"BFsrep16706_CR5","unstructured":"Proceedings of the IARC working group on the evaluation of carcinogenic risks to humans. Epstein-Barr virus and Kaposi's sarcoma herpesvirus\/human herpesvirus 8. Lyon, france, 17-24 june 1997. IARC Monogr Eval Carcinog Risks Hum 70, 1\u2013492 (1997)."},{"key":"BFsrep16706_CR6","first-page":"661","volume":"5","author":"S Pittaluga","year":"1992","unstructured":"Pittaluga, S., Loke, S. L., So, K. C., Cheung, K. N. & Ma, L. Clonal epstein-barr virus in lymphoepithelioma-like carcinoma of the stomach: Demonstration of viral genome by in situ hybridization and southern blot analysis. Mod Pathol 5, 661\u2013664 (1992).","journal-title":"Mod Pathol"},{"key":"BFsrep16706_CR7","first-page":"213","volume":"2","author":"D Shibata","year":"1993","unstructured":"Shibata, D., Hawes, D., Stemmermann, G. N. & Weiss, L. M. Epstein-Barr virus-associated gastric adenocarcinoma among japanese americans in Hawaii. Cancer Epidemiol Biomarkers Prev 2, 213\u2013217 (1993).","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFsrep16706_CR8","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/ijc.2910220305","volume":"22","author":"RJ Biggar","year":"1978","unstructured":"Biggar, R. J. et al. Primary Epstein-Barr virus infections in African infants. Ii. Clinical and serological observations during seroconversion. Int J Cancer 22, 244\u2013250 (1978).","journal-title":"Int J Cancer"},{"key":"BFsrep16706_CR9","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1086\/499277","volume":"193","author":"SM Mbulaiteye","year":"2006","unstructured":"Mbulaiteye, S. M. et al. High levels of Epstein-Barr virus DNA in saliva and peripheral blood from ugandan mother-child pairs. J Infect Dis 193, 422\u2013426 (2006).","journal-title":"J Infect Dis"},{"key":"BFsrep16706_CR10","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1056\/NEJMra032015","volume":"350","author":"DA Thorley-Lawson","year":"2004","unstructured":"Thorley-Lawson, D. A. & Gross, A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 350, 1328\u20131337 (2004).","journal-title":"N Engl J Med"},{"key":"BFsrep16706_CR11","first-page":"177","volume":"13","author":"K Bhatia","year":"1996","unstructured":"Bhatia, K. et al. Variation in the sequence of Epstein Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt's lymphomas. Oncogene 13, 177\u2013181 (1996).","journal-title":"Oncogene"},{"key":"BFsrep16706_CR12","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1056\/NEJM198109243051305","volume":"305","author":"JL Ziegler","year":"1981","unstructured":"Ziegler, J. L. Burkitt's lymphoma. N Engl J Med 305, 735\u2013745 (1981).","journal-title":"N Engl J Med"},{"key":"BFsrep16706_CR13","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/274756a0","volume":"274","author":"G de-The","year":"1978","unstructured":"de-The, G. et al. Epidemiological evidence for causal relationship between Epstein-Barr virus and Burkitt's lymphoma from Ugandan prospective study. Nature 274, 756\u2013761 (1978).","journal-title":"Nature"},{"key":"BFsrep16706_CR14","first-page":"49","volume":"39","author":"G de-The","year":"1985","unstructured":"de-The, G. The Epstein-Barr Virus (EBV): A Rosetta Stone for understanding the role of viruses in immunopathological disorders and in human carcinogenesis. Biomed Pharmacother 39, 49\u201351 (1985).","journal-title":"Biomed Pharmacother"},{"key":"BFsrep16706_CR15","doi-asserted-by":"publisher","first-page":"B194","DOI":"10.1016\/j.vaccine.2012.09.041","volume":"31","author":"JI Cohen","year":"2013","unstructured":"Cohen, J. I., Mocarski, E. S., Raab-Traub, N., Corey, L. & Nabel, G. J. The need and challenges for development of an Epstein-Barr virus vaccine. Vaccine 31 Suppl 2, B194\u2013196 (2013).","journal-title":"Vaccine"},{"key":"BFsrep16706_CR16","doi-asserted-by":"crossref","unstructured":"What we could do with an ebv vaccine. Lancet 1, 759\u2013761 (1981).","DOI":"10.1016\/S0140-6736(81)92629-5"},{"key":"BFsrep16706_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1126\/scitranslmed.3002878","volume":"3","author":"JI Cohen","year":"2011","unstructured":"Cohen, J. I., Fauci, A. S., Varmus, H. & Nabel, G. J. Epstein-Barr virus: An important vaccine target for cancer prevention. Sci Transl Med 3, 107 (2011).","journal-title":"Sci Transl Med"},{"key":"BFsrep16706_CR18","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.virusres.2009.07.005","volume":"143","author":"CM Chang","year":"2009","unstructured":"Chang, C. M., Yu, K. J., Mbulaiteye, S. M., Hildesheim, A. & Bhatia, K. The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: A need for reappraisal. Virus Res 143, 209\u2013221 (2009).","journal-title":"Virus Res"},{"key":"BFsrep16706_CR19","first-page":"875","volume":"6","author":"WL Goldschmidts","year":"1992","unstructured":"Goldschmidts, W. L. et al. Epstein-Barr virus genotypes in AIDS-associated lymphomas are similar to those in endemic Burkitt's lymphomas. Leukemia 6, 875\u2013878 (1992).","journal-title":"Leukemia"},{"key":"BFsrep16706_CR20","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1093\/jnci\/94.23.1757","volume":"94","author":"MI Gutierrez","year":"2002","unstructured":"Gutierrez, M. I. et al. Discrete alterations in the BZLF1 promoter in tumor and non-tumor-associated Epstein-Barr virus. JNCI 94, 1757\u20131763 (2002).","journal-title":"JNCI"},{"key":"BFsrep16706_CR21","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1128\/JCM.05778-11","volume":"50","author":"MA Lorenzetti","year":"2012","unstructured":"Lorenzetti, M. A. et al. Distinctive epstein-barr virus variants associated with benign and malignant pediatric pathologies: LMP1 sequence characterization and linkage with other viral gene polymorphisms. J Clin Microbiol 50, 609\u2013618 (2012).","journal-title":"J Clin Microbiol"},{"key":"BFsrep16706_CR22","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1002\/jmv.23911","volume":"86","author":"Y Yang","year":"2014","unstructured":"Yang, Y. et al. Sequence analysis of EBV immediate-early gene BZLF11 and BRLF1 in lymphomas. J Med Virol 86, 1788\u20131795 (2014).","journal-title":"J Med Virol"},{"key":"BFsrep16706_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.canlet.2004.01.035","volume":"211","author":"XS Zhang","year":"2004","unstructured":"Zhang, X. S. et al. V-val subtype of Epstein-Barr virus nuclear antigen 1 preferentially exists in biopsies of nasopharyngeal carcinoma. Cancer Lett 211, 11\u201318 (2004).","journal-title":"Cancer Lett"},{"key":"BFsrep16706_CR24","doi-asserted-by":"publisher","first-page":"958","DOI":"10.3892\/or.2014.3625","volume":"33","author":"M Chao","year":"2015","unstructured":"Chao, M., Wang, H. N., Lu, Y. J., Chang, Y. S. & Yu, J. S. The v-val subtype Eepstein-Barr virus nuclear antigen 1 promotes cell survival after serum withdrawal. Oncol Rep 33, 958\u2013966 (2015).","journal-title":"Oncol Rep"},{"key":"BFsrep16706_CR25","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1099\/vir.0.030023-0","volume":"92","author":"A Sawada","year":"2011","unstructured":"Sawada, A. et al. Epstein-Barr virus latent gene sequences as geographical markers of viral origin: Unique EBNA3 gene signatures identify Japanese viruses as distinct members of the asian virus family. J Gen Virol 92, 1032\u20131043 (2011).","journal-title":"J Gen Virol"},{"key":"BFsrep16706_CR26","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1136\/mp.53.5.280","volume":"53","author":"K Sandvej","year":"2000","unstructured":"Sandvej, K., Andresen, B. S., Zhou, X. G., Gregersen, N. & Hamilton-Dutoit, S. Analysis of the epstein-barr virus (ebv) latent membrane protein 1 (LMP-1) gene and promoter in hodgkin's disease isolates: Selection against ebv variants with mutations in the LMP-1 promoter ATF-1\/CREB-1 binding site. Mol Path 53, 280\u2013288 (2000).","journal-title":"Mol Path"},{"key":"BFsrep16706_CR27","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1182\/blood.V90.1.323.323_323_330","volume":"90","author":"K Sandvej","year":"1997","unstructured":"Sandvej, K. et al. Sequence analysis of the Epstein-Barr virus (EBV) latent membrane protein-1 gene and promoter region: Identification of four variants among wild-type EBV isolates. Blood 90, 323\u2013330 (1997).","journal-title":"Blood"},{"key":"BFsrep16706_CR28","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.jinf.2006.04.015","volume":"54","author":"M Martini","year":"2007","unstructured":"Martini, M. et al. Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in aids-related lymphomas. J Infect 54, 298\u2013306 (2007).","journal-title":"J Infect"},{"key":"BFsrep16706_CR29","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1128\/jvi.64.9.4084-4092.1990","volume":"64","author":"J Sample","year":"1990","unstructured":"Sample, J. et al. Epstein-Barr virus types 1 and 2 differ in their EBNA-3a, EBNA-3b and EBNA-3c genes. J Virol 64, 4084\u20134092 (1990).","journal-title":"J Virol"},{"key":"BFsrep16706_CR30","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/310207a0","volume":"310","author":"R Baer","year":"1984","unstructured":"Baer, R. et al. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310, 207\u2013211 (1984).","journal-title":"Nature"},{"key":"BFsrep16706_CR31","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.virol.2006.01.015","volume":"350","author":"A Dolan","year":"2006","unstructured":"Dolan, A., Addison, C., Gatherer, D., Davison, A. J. & McGeoch, D. J. The genome of epstein-barr virus type 2 strain ag876. Virology 350, 164\u2013170 (2006).","journal-title":"Virology"},{"key":"BFsrep16706_CR32","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1128\/JVI.02517-12","volume":"87","author":"Z Lin","year":"2013","unstructured":"Lin, Z. et al. Whole-genome sequencing of the akata and mutu Epstein-Barr virus strains. J Virol 87, 1172\u20131182 (2013).","journal-title":"J Virol"},{"key":"BFsrep16706_CR33","doi-asserted-by":"publisher","first-page":"e36939","DOI":"10.1371\/journal.pone.0036939","volume":"7","author":"H Kwok","year":"2012","unstructured":"Kwok, H. et al. Genomic sequencing and comparative analysis of Epstein-Barr virus genome isolated from primary nasopharyngeal carcinoma biopsy. PloS One 7, e36939 (2012).","journal-title":"PloS One"},{"key":"BFsrep16706_CR34","doi-asserted-by":"publisher","first-page":"10662","DOI":"10.1128\/JVI.01665-14","volume":"88","author":"H Kwok","year":"2014","unstructured":"Kwok, H. et al. Genomic diversity of Epstein-Barr virus genomes isolated from primary nasopharyngeal carcinoma biopsy samples. J Virol 88, 10662\u201310672 (2014).","journal-title":"J Virol"},{"key":"BFsrep16706_CR35","doi-asserted-by":"publisher","first-page":"11291","DOI":"10.1128\/JVI.00823-11","volume":"85","author":"P Liu","year":"2011","unstructured":"Liu, P. et al. Direct sequencing and characterization of a clinical isolate of Epstein-Barr virus from nasopharyngeal carcinoma tissue by using next-generation sequencing technology. J Virol 85, 11291\u201311299 (2011).","journal-title":"J Virol"},{"key":"BFsrep16706_CR36","doi-asserted-by":"publisher","first-page":"5222","DOI":"10.1128\/JVI.03614-14","volume":"89","author":"AL Palser","year":"2015","unstructured":"Palser, A. L. et al. Genome diversity of Epstein-Barr virus from multiple tumour types and normal infection. J Virol 89, 5222\u20135237 (2015).","journal-title":"J Virol"},{"key":"BFsrep16706_CR37","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1186\/1471-2164-14-804","volume":"14","author":"H Lei","year":"2013","unstructured":"Lei, H. et al. Identification and characterization of EBV genomes in spontaneously immortalized human peripheral blood B lymphocytes by NGS technology. BMC Genomics 14, 804 (2013).","journal-title":"BMC Genomics"},{"key":"BFsrep16706_CR38","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1093\/gbe\/evu054","volume":"6","author":"G Santpere","year":"2014","unstructured":"Santpere, G. et al. Genome-wide analysis of wild-type Epstein-Barr virus genomes derived from healthy individuals of the 1000 genomes project. Genome Biol Evol 6, 846\u2013860 (2014).","journal-title":"Genome Biol Evol"},{"key":"BFsrep16706_CR39","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/nrmicro2015","volume":"6","author":"DA Thorley-Lawson","year":"2008","unstructured":"Thorley-Lawson, D. A. & Allday, M. J. The curious case of the tumour virus: 50 years of Burkitt's lymphoma. Nat Rev Microbiol 6, 913\u2013924 (2008).","journal-title":"Nat Rev Microbiol"},{"key":"BFsrep16706_CR40","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0168-1702(95)00021-H","volume":"37","author":"ML Chen","year":"1995","unstructured":"Chen, M. L., Wu, R. C., Liu, S. T. & Chang, Y. S. Characterization of 5'-upstream sequence of the latent membrane protein 1 (LMP-1) gene of an Epstein-Barr virus identified in nasopharyngeal carcinoma tissues. Virus Res 37, 75\u201384 (1995).","journal-title":"Virus Res"},{"key":"BFsrep16706_CR41","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1099\/vir.0.82771-0","volume":"88","author":"A Jansson","year":"2007","unstructured":"Jansson, A., Johansson, P., Li, S. & Rymo, L. Activity of the LMP1 gene promoter in epstein-barr virus-transformed cell lines is modulated by sequence variations in the promoter-proximal cre site. J Gen Virol 88, 1887\u20131894 (2007).","journal-title":"J Gen Virol"},{"key":"BFsrep16706_CR42","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1099\/0022-1317-76-1-139","volume":"76","author":"P Busson","year":"1995","unstructured":"Busson, P., Edwards, R. H., Tursz, T. & Raab-Traub, N. Sequence polymorphism in the Epstein-Barr virus latent membrane protein (LMP)-2 gene. J Gen Virol 76(Pt 1), 139\u2013145 (1995).","journal-title":"J Gen Virol"},{"key":"BFsrep16706_CR43","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1086\/314672","volume":"179","author":"DM Walling","year":"1999","unstructured":"Walling, D. M. et al. The molecular epidemiology and evolution of Epstein-Barr virus: Sequence variation and genetic recombination in the latent membrane protein-1 gene. J Infect Dis 179, 763\u2013774 (1999).","journal-title":"J Infect Dis"},{"key":"BFsrep16706_CR44","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1093\/jnci\/57.5.1051","volume":"57","author":"F Nkrumah","year":"1976","unstructured":"Nkrumah, F. et al. Burkitt's lymphoma: Its clinical course in relation to immunologic reactivities to Epstein-Barr virus and tumor-related antigens. JNCI 57, 1051\u20131056 (1976).","journal-title":"JNCI"},{"key":"BFsrep16706_CR45","unstructured":"Nkrumah, F. K. Changes in the presentation of Burkitt's lymphoma in Ghana over a 15-year period (1969-1982). IARC Scient Pub, 665\u2013674 (1984)."},{"key":"BFsrep16706_CR46","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1182\/blood.V79.12.3261.3261","volume":"79","author":"MI Gutierrez","year":"1992","unstructured":"Gutierrez, M. I. et al. Molecular epidemiology of Burkitt's lymphoma from south america: Differences in breakpoint location and epstein-barr virus association from tumors in other world regions. Blood 79, 3261\u20133266 (1992).","journal-title":"Blood"},{"key":"BFsrep16706_CR47","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1093\/molbev\/msr121","volume":"28","author":"K Tamura","year":"2011","unstructured":"Tamura, K. et al. Mega5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance and maximum parsimony methods. Mol Biol Evol 28, 2731\u20132739 (2011).","journal-title":"Mol Biol Evol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep16706.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep16706","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep16706.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T19:09:24Z","timestamp":1672945764000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep16706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,23]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12,22]]}},"alternative-id":["BFsrep16706"],"URL":"https:\/\/doi.org\/10.1038\/srep16706","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,23]]},"assertion":[{"value":"1 July 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"16706"}}